PL
PL · PL · PL-100430200
Ritonavir Aurovitas
ATC J05AE03
Last synced from URPL (Poland) on
Identification
ManufacturerAurovitas Pharma Polska Sp. z o.o.
CountryPL (PL)
ATC codeJ05AE03
Dispensing—
ReimbursedNo
SourceURPL (Poland)
Last synced6/14/2026
Packs · 2
- gtin05909991476007
- gtin05909991476014
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "100 mg",
"packaging": "05909991476007 ¦ Rpz ¦ 143700\n30 tabl. w blistrze\n05909991476014 ¦ Rpz ¦ 143701\n30 tabl. w pojemniku",
"substance": "Ritonavirum 100 mg",
"common_name": "Ritonavirum",
"pl_product_id": "100430200",
"pozwolenie_nr": "26906",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}Related drugs
Other records sharing ATC code J05AE03.
- CAAURO-RITONAVIRAURO PHARMA INC
- IEKaletraAbbVie Deutschland GmbH & Co. KG
- IEKaletra (80 mg + 20 mg)/ml oral solutionAbbVie Deutschland GmbH & Co. KG
- IELopinavir/Ritonavir Viatris 100 mg/25 mg film-coated tabletsViatris Limited
- DKNorvirAbbVie Deutschland GmbH & Co. KG
- PLNorvirAbbVie Deutschland GmbH & Co. KG
- PLNorvirAbbVie Deutschland GmbH & Co. KG
- 🇨🇭NorvirAbbVie AG
Access this data programmatically
Query Ritonavir Aurovitas and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.